A citation-based method for searching scientific literature

Sung-Hwa Sohn, Bohyun Kim, Hee Jung Sul, Bo Youn Choi, Hyeong Su Kim, Dae Young Zang. Onco Targets Ther 2020
Times Cited: 15







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
20

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
20

Downregulation of miR-218-5p promotes invasion of oral squamous cell carcinoma cells via activation of CD44-ROCK signaling.
Xiaojie Li, Jianya He, Miaomiao Shao, Bai Cui, Fei Peng, Jiao Li, Yan Ran, Dong Jin, Jing Kong, Jinming Chang,[...]. Biomed Pharmacother 2018
33
13

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
L Schmidt, K Junker, N Nakaigawa, T Kinjerski, G Weirich, M Miller, I Lubensky, H P Neumann, H Brauch, J Decker,[...]. Oncogene 1999
377
13

c-Met targeting in advanced gastric cancer: An open challenge.
Luigi Marano, Rita Chiari, Alessio Fabozzi, Ferdinando De Vita, Virginia Boccardi, Giandomenico Roviello, Roberto Petrioli, Daniele Marrelli, Franco Roviello, Alberto Patriti. Cancer Lett 2015
49
13

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.
Charles S Fuchs, Jiri Tomasek, Cho Jae Yong, Filip Dumitru, Rodolfo Passalacqua, Chanchal Goswami, Howard Safran, Lucas Vieira Dos Santos, Giuseppe Aprile, David R Ferry,[...]. Lancet 2014
13

Met, metastasis, motility and more.
Carmen Birchmeier, Walter Birchmeier, Ermanno Gherardi, George F Vande Woude. Nat Rev Mol Cell Biol 2003
13

MET expression and amplification in patients with localized gastric cancer.
Yelena Y Janjigian, Laura H Tang, Daniel G Coit, David P Kelsen, Todd D Francone, Martin R Weiser, Suresh C Jhanwar, Manish A Shah. Cancer Epidemiol Biomarkers Prev 2011
126
13

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial.
Daniel V T Catenacci, Niall C Tebbutt, Irina Davidenko, André M Murad, Salah-Eddin Al-Batran, David H Ilson, Sergei Tjulandin, Evengy Gotovkin, Boguslawa Karaszewska, Igor Bondarenko,[...]. Lancet Oncol 2017
183
13

Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models.
Paul R Gavine, Yongxin Ren, Lu Han, Jing Lv, Shiming Fan, Wei Zhang, Wen Xu, Yuan Jie Liu, Tianwei Zhang, Haihua Fu,[...]. Mol Oncol 2015
78
13

Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met.
Guang-Zong Chen, Wang-Shu Dai, Hong-Cheng Zhu, Hong-Mei Song, Xi Yang, Yuan-Dong Wang, Hua Min, Qian Lu, Shu Liu, Xin-Chen Sun,[...]. J Cancer 2017
19
13

Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors.
David S Hong, Patricia LoRusso, Omid Hamid, Filip Janku, Muaiad Kittaneh, Daniel V T Catenacci, Emily Chan, Tanios Bekaii-Saab, Shirish M Gadgeel, Robert D Loberg,[...]. Clin Cancer Res 2019
30
13

A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction.
Manish A Shah, Jae-Yong Cho, Iain B Tan, Niall C Tebbutt, Chia-Jui Yen, Alice Kang, David S Shames, Lilian Bu, Yoon-Koo Kang. Oncologist 2016
63
13

Developing c-MET pathway inhibitors for cancer therapy: progress and challenges.
Xiangdong Liu, Robert C Newton, Peggy A Scherle. Trends Mol Med 2010
146
13

A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer.
Daisuke Sakai, Hyun Cheol Chung, Do-Youn Oh, Se Hoon Park, Shigenori Kadowaki, Yeul Hong Kim, Akihito Tsuji, Yoshito Komatsu, Yoon-Koo Kang, Kazunori Uenaka,[...]. Cancer Chemother Pharmacol 2017
19
13

Immune Checkpoint Blockade in Cancer Therapy.
Michael A Postow, Margaret K Callahan, Jedd D Wolchok. J Clin Oncol 2015
13


Tepotinib Inhibits the Epithelial-Mesenchymal Transition and Tumor Growth of Gastric Cancers by Increasing GSK3β, E-Cadherin, and Mucin 5AC and 6 Levels.
Sung-Hwa Sohn, Hee Jung Sul, Bohyun Kim, Bum Jun Kim, Hyeong Su Kim, Dae Young Zang. Int J Mol Sci 2020
6
33


First-in-Human Phase I, Dose-Escalation and -Expansion Study of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, in Patients With Advanced Solid Tumors.
John H Strickler, Colin D Weekes, John Nemunaitis, Ramesh K Ramanathan, Rebecca S Heist, Daniel Morgensztern, Eric Angevin, Todd M Bauer, Huibin Yue, Monica Motwani,[...]. J Clin Oncol 2018
55
13

CD44+ gastric cancer cells with stemness properties are chemoradioresistant and highly invasive.
Mao Sun, Wei Zhou, Yun-Yun Zhang, Dong-Lin Wang, Xiao-Ling Wu. Oncol Lett 2013
21
6


LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
Ren Wang, Hui-Xing Dong, Jian Zeng, Jing Pan, Xiao-Yan Jin. J Cell Physiol 2018
45
6

ARPP-16/ARPP-19: a highly conserved family of cAMP-regulated phosphoproteins.
I Dulubova, A Horiuchi, G L Snyder, J A Girault, A J Czernik, L Shao, R Ramabhadran, P Greengard, A C Nairn. J Neurochem 2001
43
6

microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer.
Yiran Zhou, Ruhong Li, Haidong Yu, Ruotian Wang, Zhiqiang Shen. Onco Targets Ther 2017
18
6

Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance.
Qiang Zuo, Jing Liu, Jingwen Zhang, Mengwan Wu, Lihong Guo, Wangjun Liao. Sci Rep 2015
34
6


Corrigendum to "HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway" [BBA - Mol. Cell Res. 1866 (2019) 750-760].
Shimeng Pan, Yanqiu Liu, Qianqian Liu, Yang Xiao, Bing Liu, Xiang Ren, Xia Qi, Huimin Zhou, Changqian Zeng, Li Jia. Biochim Biophys Acta Mol Cell Res 2019
3
33

Increased ARPP-19 expression is associated with hepatocellular carcinoma.
Haiyan Song, Jielu Pan, Yang Liu, Hongzhu Wen, Lei Wang, Jiefeng Cui, Yinkun Liu, Bing Hu, Zemin Yao, Guang Ji. Int J Mol Sci 2014
15
6

miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
Xinliang Zhou, Xinyi Men, Riyang Zhao, Jing Han, Zhisong Fan, Yudong Wang, Yalei Lv, Jing Zuo, Lianmei Zhao, Meixiang Sang,[...]. Cancer Gene Ther 2018
44
6

The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.
Jiaolong Shi, Fengping Li, Xingxing Yao, Tingyu Mou, Zhijun Xu, Zheng Han, Siyu Chen, Wende Li, Jiang Yu, Xiaolong Qi,[...]. Oncogene 2018
38
6

NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Sheng Tan, Hua Li, Weijie Zhang, Yunying Shao, Yuan Liu, Haiyang Guan, Jun Wu, Yani Kang, Junsong Zhao, Qing Yu,[...]. Oncogene 2018
53
6

Acquisition of resistance to trastuzumab in gastric cancer cells is associated with activation of IL-6/STAT3/Jagged-1/Notch positive feedback loop.
Zhengyan Yang, Liang Guo, Dan Liu, Limin Sun, Hongyu Chen, Que Deng, Yanjun Liu, Ming Yu, Yuanfang Ma, Ning Guo,[...]. Oncotarget 2015
71
6

Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
Axel Schulenburg, Katharina Blatt, Sabine Cerny-Reiterer, Irina Sadovnik, Harald Herrmann, Brigitte Marian, Thomas W Grunt, Christoph C Zielinski, Peter Valent. J Hematol Oncol 2015
66
6

MiR-26a performs converse roles in proliferation and metastasis of different gastric cancer cells via regulating of PTEN expression.
Keshuo Ding, Zhengsheng Wu, Nana Wang, Xiaonan Wang, Yuejun Wang, Pengxu Qian, Gang Meng, Sheng Tan. Pathol Res Pract 2017
31
6

Targeted therapies for gastric cancer: failures and hopes from clinical trials.
Maria Apicella, Simona Corso, Silvia Giordano. Oncotarget 2017
76
6

Arpp19 Promotes Myc and Cip2a Expression and Associates with Patient Relapse in Acute Myeloid Leukemia.
Eleonora Mäkelä, Eliisa Löyttyniemi, Urpu Salmenniemi, Otto Kauko, Taru Varila, Veli Kairisto, Maija Itälä-Remes, Jukka Westermarck. Cancers (Basel) 2019
7
14

EGCG inhibits CSC-like properties through targeting miR-485/CD44 axis in A549-cisplatin resistant cells.
Pan Jiang, Chuyue Xu, Lijun Chen, Aochang Chen, Xiaoyue Wu, Ming Zhou, Ijaz Ul Haq, Zahula Mariyam, Qing Feng. Mol Carcinog 2018
25
6

The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.
Kojiro Eto, Masaaki Iwatsuki, Masayuki Watanabe, Takatsugu Ishimoto, Satoshi Ida, Yu Imamura, Shiro Iwagami, Yoshifumi Baba, Yasuo Sakamoto, Yuji Miyamoto,[...]. Int J Cancer 2015
69
6

Inhibition of epithelial‑mesenchymal transition in gastric cancer cells by miR‑711‑mediated downregulation of CD44 expression.
Wei-Sheng Xiao, De-Feng Li, Ya-Ping Tang, Yan-Zhu Chen, Wen-Bing Deng, Juan Chen, Wei-Wei Zhou, Ai-Jun Liao. Oncol Rep 2018
8
12

Nerve growth factor controls GAP-43 mRNA stability via the phosphoprotein ARPP-19.
Nina Irwin, Steven Chao, Luda Goritchenko, Atsuko Horiuchi, Paul Greengard, Angus C Nairn, Larry I Benowitz. Proc Natl Acad Sci U S A 2002
48
6

c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma.
Pie-Che Chen, Chih-Chia Yu, Wen-Yu Huang, Wan-Hong Huang, Yu-Ming Chuang, Ru-Inn Lin, Jora M J Lin, Hon-Yi Lin, Yeong-Chin Jou, Cheng-Huang Shen,[...]. Cancers (Basel) 2019
8
12

NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer.
Laiqin Tang, Zhiguo Long, Na Zhao, Guangjia Feng, Xianzhi Guo, Minghua Yu. J Cell Biochem 2018
16
6

ARPP-19 promotes proliferation and metastasis of human glioma.
Tao Jiang, Bing Zhao, Xiaocan Li, Jinghai Wan. Neuroreport 2016
20
6

EPHA5 mediates trastuzumab resistance in HER2-positive breast cancers through regulating cancer stem cell-like properties.
Yongfei Li, Jiahui Chu, Wanting Feng, Mengzhu Yang, Yanhong Zhang, Yanqiu Zhang, Ye Qin, Juan Xu, Jun Li, Shauna N Vasilatos,[...]. FASEB J 2019
15
6

Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
Xiao Xiao He, Li Ding, Yuan Lin, Man Shu, Jian Ming Wen, Ling Xue. J Clin Pathol 2015
20
6

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
Michael F Clarke, John E Dick, Peter B Dirks, Connie J Eaves, Catriona H M Jamieson, D Leanne Jones, Jane Visvader, Irving L Weissman, Geoffrey M Wahl. Cancer Res 2006
6

Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression.
Yisi Luo, Zhongxian Tian, Xiaohui Hua, Maowen Huang, Jiheng Xu, Jingxia Li, Haishan Huang, Mitchell Cohen, Chuanshu Huang. Cell Mol Life Sci 2020
17
6

FNDC3B circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E-cadherin and CD44 expression.
Yuling Hong, Haifeng Qin, Yin Li, Yuhai Zhang, Xunrong Zhuang, Lei Liu, Kun Lu, Long Li, Xiaoling Deng, Fan Liu,[...]. J Cell Physiol 2019
52
6

microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
Beiqin Yu, Xuehua Chen, Jianfang Li, Qinlong Gu, Zhenggang Zhu, Chen Li, Liping Su, Bingya Liu. BMC Cancer 2017
28
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.